default author photo

Taylor Gardner

affiliation not provided to SSRN

  • affiliation not provided to SSRN

SCHOLARLY PAPERS

2

DOWNLOADS

110

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Bridging Evidence and Practice: An Analysis Assessing the Clinical Utility of Pediatric Neurodevelopmental Disorder Trials

Number of pages: 21 Posted: 26 Nov 2025
Lucas Martinez, Kohl Kirby, Taylor Gardner, Chance Bratten, Adam Khan, Eli Paul, Alec Young, Alicia Ito Ford and Matt Vassar
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Oklahoma State University - Tulsa - Center for Health Sciences and Oklahoma State University Tulsa - Center for Health Sciences, Department of Psychiatry and Behavioral Sciences
Downloads 69

Abstract:

Loading...

Neurodevelopmental Disorders, Randomized controlled trials, Pediatrics, Clinical utility, Pragmatism, Transparency, Patient-centered outcomes

2.

Assessing Clinical Utility in Randomized Trials of Radical Prostatectomy for Urologic Oncology: An Original Article of Studies Published between 2020 and 2024

Number of pages: 21 Posted: 05 Aug 2025
Derrick Pruitt, Pau Von, Taylor Gardner, Eli Paul, Chance Bratten, Adam Khan, Reece M. Anderson, Matt Vassar, Alec Young and Alicia Ito Ford
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Oklahoma State University - Tulsa - Center for Health Sciences, Oklahoma State University Tulsa - Center for Health Sciences, Department of Psychiatry and Behavioral Sciences, affiliation not provided to SSRN and Oklahoma State University - Tulsa - Center for Health Sciences
Downloads 41

Abstract:

Loading...

Usefulness, Transparency, Randomized controlled trials, Radical Prostatectomy, Prostatic Adenocarcinoma